Charis Eng, MD, PhD was recognized as a "Notable Woman in Healthcare" by Crain's Cleveland Business. Eng is the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine, Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, and Professor and Vice Chair of the Department of Genetics and Genome Sciences at Case Western Reserve University. She is also a member of the Case Comprehensive Cancer Center.
Excerpt from Article
Dr. Charis Eng's pioneering work to unite "cancer" and "genetics" research as a young student "set sail on an unpredictable journey that would eventually make her the leading expert in the field of clinical cancer genetics," according to Dr. Serpil Erzurum, chair of Cleveland Clinic's Lerner Research Institute. In the nomination form, Erzurum cites Eng's "tireless support, inspired mentorship and active promotion of young scientists" among her key contributions to cancer research and treatment. In addition to breakthrough training initiatives, Eng, who has directed the Genomic Medicine Institute for 13 years, is an empathetic caregiver to her patients and an active investigator, having published more than 500 peer-reviewed articles to date and serving as the principal investigator on over $50 million in lifetime grants and other funding. Her lab has led discoveries in breast and thyroid cancers, among others, as well as identified a mutation associated with Cowden disease and autism.